Keypoints: PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency has approved the expansion of the indication of Translarna (Ataluren)…
Keypoints FDA Approves Low-Dose Tablet for HIV Treatment in Virologically Suppressed Children Weighing at Least 14 kg. Biktarvy Provides an Effective Treatment…
Keypoints: Chugai, Oncolys BioPharma agree to terminate exclusive license agreement on oncolytic viral immunotherapy, OBP-301 The effective date of the termination will…
Keypoints Dr. Reddy’s Laboratories said it has received approval from the US health regulator to market Lenalidomide capsules, used to treat multiple…
The TYRVAYA nasal spray is the first approved nasal spray to treat dry eye disease. TYRVAYA nasal spray will benefit the patients…
Keypoints MSN Laboratories on Monday has launched the most affordable copies of Jardiance (Empagliflozin), the top-selling patented anti-diabetes pills sold by German…
Keypoints: The Janssen Pharmaceutical Company of Johnson & Johnson announced today that Health Canada approved OPSYNVI. OPSYNVI should be used in patients…
Keypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq treatment reduced the risk of disease recurrence…
WHO advisory group to meet on Oct 26 to decide on Bharat Biotech’s Covaxin. Covaxin manufacturer, Bharat Biotech, has been submitting data…
KEYPOINTS The FDA has given the Ki-67 IHC MIB-1 pharmDx assay a companion diagnostic approval for detecting Ki-67 expression in patients with…